Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation
Published in:
Transfuze Hematol. dnes,20, 2014, No. 4, p. 106.
Category:
Selection of press reports and books
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2014 Issue 4
- Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures
- The Importance of Hydration in Wound Healing
- Cost Effectiveness of FVIII Substitution Versus Non-Factor Therapy for Hemophilia A
- Vascular Disease in the Gradually Aging Population of Hemophiliacs: An Underestimated Problem?
- Prognostic Significance of Subclinical Joint Changes on MRI in Hemophilia
Most read in this issue
- The significance of heavy/light chain immunoglobulin pairs (Hevylite™) in multiple myeloma
- Retransfusion system with integrated double filtration – parameters of product quality
- Activity of Blood Transfusion Service in the Czech Republic 1989–2013
- Pharmacokinetics as a tool for optimising the treatment of patients with haemophilia